Title
Molecular specific and sensitive detection of pyrazinamide and its metabolite pyrazinoic acid by means of surface enhanced raman spectroscopy employing in situ prepared colloids
Date Issued
01 June 2019
Access level
open access
Resource Type
journal article
Author(s)
Muehlig A.
Jahn I.
Heidler J.
Jahn M.
Weber K.
Cialla-May D.
Popp J.
Publisher(s)
MDPI AG
Abstract
The prodrug pyrazinamide (PZA) is metabolized by the mycobacteria to pyrazinoic acid (POA), which is expelled into the extracellular environment. PZA resistance is highly associated to a lack of POA efflux. Thus, by detecting a reduction of the concentration of POA in the extracellular environment, by means of lab-on-a-chip (LoC)-SERS (surface-enhanced Raman spectroscopy), an alternative approach for the discrimination of PZA resistant mycobacteria is introduced. A droplet-based microfluidic SERS device has been employed to illustrate the potential of the LoC-SERS method for the discrimination of PZA resistant mycobacteria. The two analytes were detected discretely in aqueous solution with a limit of detection of 27 μm for PZA and 21 μm for POA. The simultaneous detection of PZA and POA in aqueous mixtures could be realized within a concentration range from 20 μm to 50 μm for PZA and from 50 μm to 80 μm for POA.
Volume
9
Issue
12
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-85068192415
Source
Applied Sciences (Switzerland)
ISSN of the container
20763417
Sponsor(s)
Funding: We gratefully acknowledge the Federal Ministry of Education and Research, Germany (BMBF) for supporting the InfectoGnostics (13GW0096F) and EXASENS (13N13856) project grants as well as BMBF and German Aerospace Center (DLR) for supporting the Myco-NET2 (01DN15028) project grant. We thank for funding the projects ERANET LAC ELAC2014/HID-0352, CONCYTEC-FONDECYT-Peru 086-2015, and the Wellcome Trust Intermediate Fellowship (grant 099805/Z/12/Z).
Sources of information:
Directorio de Producción Científica
Scopus